Guardian™ 4 CGM 
Pharmacy Copay program


If your pharmacy benefit has a high copay or out-of-pocket cost for continuous glucose monitors (CGMs), we can help make it more affordable.

Guardian™ 4 CGM 
Pharmacy Copay Program

What do I need for this program?


1
Ensure you have a prescription for the Guardian™ 4 sensor and MiniMed™ 780G system.
2
Check that you have health insurance with a pharmacy benefit coverage. Some exclusions apply.
3
Call Medtronic to verify your eligibility before placing an order.

What does it include and how much does it cost?


This copay program applies to the following products:

  • Guardian™ 4 sensor
  • Guardian™ 4 transmitter

Transmitter

Transmitter

  • 12-month warranty
  • $99 per transmitter
  • Annual maximum of $500

 

Sensor

Sensors

  • 1 box per month
  • $60 per box
  • Monthly maximum of $180 and annual max of $720

Call us to verify your eligibility


1-800-646-4633
(Monday-Friday, 8 a.m.-6 p.m. CT)


New to Medtronic? Select option 3
Ready to reorder sensors? Select option 2

Frequently asked questions


You may be eligible for this program if you meet the following requirements:

  1. You have commercial health insurance.
  2. You have a valid prescription for your Guardian™ 4 sensor and transmitter from your healthcare professional.
  3. You’re required to purchase your continuous glucose monitoring (CGM) supplies through a pharmacy.

Eligibility is determined based on insurance coverage. You can still call us at 1-800-646-4633 (Monday-Friday, 8 a.m.-6 p.m. CT) to verify both your supplies coverage and your pharmacy coverage to determine your lowest out-of-pocket cost. If you do not have any insurance coverage for the Guardian™ 4 sensor, you may be eligible for other offers from Medtronic.

This copay support program will be automatically applied to your out-of-pocket amount due when you obtain the CGM through the Medtronic Pharmacy or other pharmacy within the vendor network. 

This copay support would be applied to the amount you owe when the pharmacy claim is adjudicated.

This program is only valid for the Guardian™ 4 sensor and transmitter. 

Guardian™ 4 CGM Pharmacy Copay program Terms & Conditions

  • Valid prescription from provider required. 
  • Eligible patients: Commercially insured patients only; receiving product via their pharmacy benefit.  
  • Excluded participants include patients enrolled in any federal, state, or government-funded healthcare program such as Medicare, Medicare Advantage, Medicare Part D, Medicaid, Medigap, Veterans Affairs (VA), the Department of Defense (DoD), or TRICARE® that provides coverage for G4S, or where prohibited by law (including MA and MI).
  • If at any time a patient becomes enrolled under any such federal, state, or government-funded healthcare program, he/she will no longer be able to use this program and must call (858) 522-0252 to stop participation. 
  • Patients can receive up to a total of $500 maximum annual benefit for their annual transmitter.  Patients can receive up to a total of $720 annual benefit for their sensors, with a monthly maximum benefit of $180 per month.
  • Program valid for eligible patients filling a prescription between December 13, 2024–December 24, 2025. There is no retroactive application of this program.
  • Customer agrees not to submit any claims for rebated products to any Government Plan and will not request their pharmacy or DME supplier to submit any such claim to any Government Plan. 
  • Restrictions may apply.
  • Offer and terms and conditions are subject to change or discontinue without notice. 
  • This is not health insurance. 
  • Offer good only in the USA at participating pharmacies and cannot be redeemed at government-subsidized clinics. 

Important safety information: MiniMed™ 780G system with SmartGuard™ technology with Guardian™ 4 sensor

The MiniMed™ 780G system is intended for continuous delivery of basal insulin at selectable rates, and the administration of insulin boluses at selectable amounts for the management of type 1 diabetes mellitus in persons seven years of age and older requiring insulin as well as for the continuous monitoring and trending of glucose levels in the fluid under the skin. The MiniMed™ 780G system includes SmartGuard™ technology, which can be programmed to automatically adjust insulin delivery based on the continuous glucose monitoring (CGM) sensor glucose values and can suspend delivery of insulin when the sensor glucose (SG) value falls below or is predicted to fall below predefined threshold values.

The Medtronic MiniMed™ 780G system consists of the following devices: MiniMed™ 780G insulin pump, the Guardian™ 4 transmitter, the Guardian™ 4 sensor, One-press serter, the Accu-Chek™ Guide Link blood glucose meter, and the Accu-Chek™ Guide test strips. The system requires a prescription from a healthcare professional.

The Guardian™ 4 sensor is intended for use with the MiniMed™ 780G system and the Guardian 4 transmitter to monitor glucose levels for the management of diabetes. The sensor is intended for single use and requires a prescription. The Guardian™ 4 sensor is indicated for up to seven days of continuous use.

The Guardian™ 4 sensor is not intended to be used directly to make therapy adjustments while the MiniMed™ 780G is operating in manual mode. All therapy adjustments in manual mode should be based on measurements obtained using a blood glucose meter and not on values provided by the Guardian™ 4 sensor. The Guardian™ 4 sensor has been studied and is approved for use in patients ages 7 years and older and in the arm insertion site only. Do not use the Guardian™ 4 sensor in the abdomen or other body sites including the buttocks, due to unknown or different performance that could result in hypoglycemia or hyperglycemia.

WARNING: Do not use the SmartGuard™ feature for people who require less than 8 units or more than 250 units of total daily insulin per day. A total daily dose of at least 8 units, but no more than 250 units, is required to operate in the SmartGuard™ feature.

WARNING: Do not use the MiniMed™ 780G system until appropriate training has been received from a healthcare professional. Training is essential to ensure the safe use of the MiniMed™ 780G system.

WARNING: Do not use SG values to make treatment decisions, including delivering a bolus, while the pump is in Manual Mode. When the SmartGuard™ feature is active and you are no longer in Manual Mode, the pump uses an SG value, when available, to calculate a bolus amount. However, if your symptoms do not match the SG value, use a BG meter to confirm the SG value. Failure to confirm glucose levels when your symptoms do not match the SG value can result in the infusion of too much or too little insulin, which may cause hypoglycemia or hyperglycemia.

Pump therapy is not recommended for people whose vision or hearing does not allow for the recognition of pump signals, alerts, or alarms. The safety of the MiniMed™ 780G system has not been studied in pregnant women, persons with type 2 diabetes, or in persons using other anti-hyperglycemic therapies that do not include insulin. For complete details of the system, including product and important safety information such as indications, contraindications, warnings and precautions associated with system and its components, please consult https://www.medtronicdiabetes.com/important-safety-information#minimed-780g and the appropriate user guide at https://www.medtronicdiabetes.com/download-library